by Edel O’Connell – CARDIAC medicine has come a long way in 50 years but the dual pressures of cutbacks in the health service and an increased sedentary… read more.
by Bruce Sylvester – Following a systematic review of 26 relevant studies involving 2,959 women, Cochrane Review researchers concluded that inhaled pain relief appears to offer safe and… read more.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – Over 1,000 small and medium enterprises (SMEs) have now registered with European Medicines Agency SME office. The… read more.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The CHMP has recommended the first medical treatment for the removal of eschar from severe burn wounds.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The EMA has given the green light for the first medicine specifically for irritable bowel syndrome (IBS)… read more.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – There’s a new man at the helm of the European Medicine Agency’s most influential committee: Dr Tomas… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Adalimumab appears to be effective in maintaining remission among some pediatric patients with Crohn’s disease.
by Bruce Sylvester – Emerging use of FDA Approved Drugs – Maraviroc, an antiretroviral drugin the treatment of HIV, significantly reduces the incidence of graft-versus-host disease (GvHD) among… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – In some patients severe aplastic anemia who have failed standard therapies, eltrombopag appears to raise blood cell… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Botulinum toxin treatment appears to improve tremor in the arms and hands of persons with multiple sclerosis… read more.
by Bruce Sylvester – Older seniors, aged 85 and over, show a high burden of respiratory disease, researchers reported on September 3, 2012 at the European Respiratory Society’s… read more.
by Bruce Sylvester – Obese persons with excess visceral fat appear to be at an increased risk of developing Type 2 diabetes,
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
